Evidence map›Paper›PMID 20570913›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2010

Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium.

Linda E Kelemen, Marc T Goodman, Valerie McGuire, Mary Anne Rossing, Penelope M Webb, Australian Cancer Study (Ovarian Cancer) Study Group, Martin Köbel, Hoda Anton-Culver, Jonathan Beesley, Andrew Berchuck and 39 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 3 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 3 syntheses or guidelines pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Lack of association between MTHFD1 G401A polymorphism and ovarian cancer susceptibility.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Pooled it
  3. Pooled it
  4. Common Variants in One-Carbon Metabolism Genes (International journal of molecular sciences · 2023
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Biomarker-based ovarian carcinoma typing: a histologic investigation in the ovarian tumor tissue analysis consortium.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2013
    Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

49 authors at 10 institutions in 4 countries.

Linda E KelemenDepartment of Population Health Research, Alberta Health Services-Cancer Care, 1331 29th Street Northwest, Calgary, Alberta T2N4N2, Canada. lkelemen@post.harvard.edu
Marc T Goodman
Valerie McGuire
Mary Anne Rossing
Penelope M Webb
Australian Cancer Study (Ovarian Cancer) Study Group
Martin Köbel
Hoda Anton-Culver
Jonathan Beesley
Andrew Berchuck
Sony Brar
Michael E Carney
Jenny Chang-Claude
Georgia Chenevix-Trench
Australian Ovarian Cancer Study Group
Daniel W Cramer
Julie M Cunningham
Richard A Dicioccio
Jennifer A Doherty
Douglas F Easton
Zachary S Fredericksen
Brooke L Fridley
Margaret A Gates
Simon A Gayther
Aleksandra Gentry-Maharaj
Estrid Høgdall
Susanne Krüger Kjaer
Galina Lurie
Usha Menon
Patricia G Moorman
Kirsten Moysich
Roberta B Ness
Rachel T Palmieri
Celeste L Pearce
Paul D P Pharoah
Susan J Ramus
Honglin Song
Daniel O Stram
Shelley S Tworoger
David Van Den Berg
Robert A Vierkant
Shan Wang-Gohrke
Alice S Whittemore
Lynne R Wilkens
Anna H Wu
Joellen M Schildkraut
Thomas A Sellers
Ellen L Goode
Ovarian Cancer Association Consortium
University of Hawaiʻi at Mānoa · USAlberta Health Services · CAQIMR Berghofer Medical Research Institute · AUUniversity Hospital Heidelberg · DEUniversity of Hawaii System · USCancer Research Center · USUniversity of Calgary · CACancer Care Services · USHeidelberg University · DEFred Hutch Cancer Center · US

Funding

USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORTP30CA014089 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Fumito Ito · 1985 to 2026
$181.4M
Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI MARK G FRATTINI · 1985 to 2026
$116.6M
Statistical MethodsP01CA087969 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI TWOROGER, SHELLEY S · 2000 to 2019
$77.8M
GENETIC SUSCEPTIBILITY TO CANCER IN MULTIETHNIC COHORTSR01CA063464 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HENDERSON, BRIAN E · 2001 to 2005
$23.2M
Northern California Cooperative Family Registry for Breast CancerU01CA069417 · NCI · NORTHERN CALIFORNIA CANCER CENTER · PI JOHN, ESTHER M. · 1995 to 2010
$22.4M
USC CANCER EPIDEMIOLOGY &BIOSTATISTICS UNITP01CA017054 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HENDERSON, BRIAN E · 1985 to 2009
$18.2M
Training Program in Cancer EpidemiologyT32CA009001 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI A. Heather Eliassen, Meir Stampfer · 1985 to 2026
$17.3M
BIOCHEMICAL MARKERS IN THE NURSES'HEALTH STUDY COHORTR01CA049449 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI HANKINSON, SUSAN E · 1989 to 2008
$11.3M
COLLABORATIVE STUDY OF OVARIAN CANCER IN TWO RISK GROUPSR01CA058598 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI GOODMAN, MARC T · 1993 to 2012
$4.6M
Epidemiology of Ovarian Cancer:New HypothesesR01CA087538 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ROSSING, MARY ANNE · 2002 to 2006
$3.5M
Steroid Hormone Genes and Ovarian Cancer RiskR01CA112523 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ROSSING, MARY ANNE · 2006 to 2010
$3.3M
Genetic Variation in the NF-kappaB Pathway and Ovarian Cancer EtiologyR01CA122443 · NCI · MAYO CLINIC ROCHESTER · PI GOODE, ELLEN L. · 2007 to 2012
$2.7M
Cancer Research UK 10118Cancer Research UK 10119Cancer Research UK 10124Cancer Research UK 11021Cancer Research UK 11022Cancer Research UK A10119Cancer Research UK A10124CIHR MSH-87734Medical Research Council G0801875NCI NIH HHS CA112523NCI NIH HHS CA14089NCI NIH HHS CA17054NCI NIH HHS CA61132NCI NIH HHS CA63464NCI NIH HHS CA87538NCI NIH HHS N01-CN-55424NCI NIH HHS N01 PC035137NCI NIH HHS N01 PC067010NCI NIH HHS N01-PC-67001NCI NIH HHS P01 CA017054NCI NIH HHS P01 CA087969NCI NIH HHS P01 CA87969NCI NIH HHS P30 CA014089NCI NIH HHS P30 CA016056NCI NIH HHS R01 CA049449NCI NIH HHS R01 CA058598NCI NIH HHS R01 CA063464NCI NIH HHS R01 CA087538NCI NIH HHS R01 CA088868NCI NIH HHS R01 CA112523NCI NIH HHS R01 CA 122443NCI NIH HHS R01 CA122443NCI NIH HHS R01 CA16056NCI NIH HHS R01 CA49449NCI NIH HHS R01 CA 58598NCI NIH HHS R01 CA 61107NCI NIH HHS R01 CA 88868NCI NIH HHS R03 CA113148NCI NIH HHS R03-CA113148NCI NIH HHS T32 CA009001NCI NIH HHS U01 CA063464NCI NIH HHS U01 CA069417NCI NIH HHS U01 CA69417NCI NIH HHS U01 CA71966
6 · The paper itself

Abstract

backgroundWe previously reported the risks of ovarian carcinoma for common polymorphisms in one-carbon transfer genes. We sought to replicate associations for DPYD rs1801265, DNMT3A rs13420827, MTHFD1 rs1950902, MTHFS rs17284990, and TYMS rs495139 with risk of ovarian carcinoma overall and to use the large sample of assembled cases to investigate associations by histologic type.

methodsAssociations were evaluated in the Ovarian Cancer Association Consortium, including 16 studies of 5,593 epithelial ovarian carcinoma cases and 9,962 controls of white non-Hispanic origin. Odds ratios (OR) and 95% confidence intervals (CI) were adjusted for age and study site.

resultsThe five polymorphisms were not associated with ovarian carcinoma overall (P(trend) > 0.13); however, associations for the minor allele at TYMS rs495139 were observed for carcinomas of mucinous type (OR, 1.19; 95% CI, 1.03-1.39; P = 0.02), clear cell type (OR, 0.86; 95% CI, 0.75-0.99; P = 0.04), and endometrioid type (OR, 0.90; 95% CI, 0.81-0.99; P = 0.04; P(heterogeneity) = 0.001). Restriction to low-grade mucinous carcinomas further strengthened the association for the mucinous type (OR, 1.32; 95% CI, 1.07-1.62; P = 0.01). TYMS rs495139 was not associated with serous type (OR, 1.06; 95% CI, 1.00-1.13; P = 0.05).

conclusionsTYMS rs495139 may be associated with a differential risk of ovarian carcinoma types, indicating the importance of accurate histopathologic classification. IMPACT: Biomarkers that distinguish ovarian carcinoma types are few, and TYMS rs495139 may provide a novel clue to type etiology.

Indexed as

AdultAgedBiomarkers, TumorCarbon-Nitrogen LigasesCase-Control StudiesDihydrouracil Dehydrogenase (NADP)DNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3AFemaleFolic AcidGenetic Predisposition to DiseaseGenetic VariationGenotypeHumansMethylenetetrahydrofolate Dehydrogenase (NADP)Middle Aged5,10-methenyltetrahydrofolate synthetaseBiomarkers, TumorCarbon-Nitrogen LigasesDihydrouracil Dehydrogenase (NADP)DNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3ADNMT3A protein, humanFolic AcidMethylenetetrahydrofolate Dehydrogenase (NADP)Minor Histocompatibility AntigensMTHFD1 protein, humanThymidylate Synthase

Identifiers

PMID20570913
PMCPMC3013232
OpenAlexW2125777364

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.